Israel Englander Legend Biotech Corp Transaction History

Millennium Management LLC

$192 Billion
Q2 2025

A detailed history of Israel Englander (Millennium Management LLC) transactions in Legend Biotech Corp stock. As of the latest transaction made, Millennium Management LLC holds 14,000 shares of LEGN stock, worth $517,860. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,000

Previous 40,000 65.0%

Holding current value

$517,860

Previous $1.36 Million 63.45%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$27.69 - $37.91 $3.26 Million - $4.46 Million	-117,642 Reduced 13.7%	740,847 $26.3 Million
Q1 2025 May 15, 2025	BUY	$31.43 - $39.7 $19 Million - $23.9 Million	603,021 Added 236.05%	858,489 $29.1 Million
Q4 2024 Feb 14, 2025	SELL	$32.49 - $50.28 $10.2 Million - $15.8 Million	-314,908 Reduced 55.21%	255,468 $8.31 Million
Q3 2024 Nov 14, 2024	SELL	$43.55 - $59.88 $47.4 Million - $65.2 Million	-1,088,305 Reduced 65.61%	570,376 $27.8 Million
Q2 2024 Aug 14, 2024	BUY	$39.5 - $57.22 $50.9 Million - $73.7 Million	1,287,590 Added 346.97%	1,658,681 $73.5 Million
Q1 2024 May 15, 2024	SELL	$55.06 - $69.99 $11.6 Million - $14.8 Million	-211,059 Reduced 36.26%	371,091 $20.8 Million
Q4 2023 Feb 14, 2024	BUY	$57.25 - $69.74 $17.8 Million - $21.7 Million	310,594 Added 114.38%	582,150 $35 Million
Q2 2023 Aug 14, 2023	SELL	$46.28 - $75.01 $12.5 Million - $20.3 Million	-270,446 Reduced 49.9%	271,556 $18.7 Million
Q1 2023 May 15, 2023	BUY	$43.42 - $57.37 $7.9 Million - $10.4 Million	181,885 Added 50.51%	542,002 $26.1 Million
Q4 2022 Feb 14, 2023	SELL	$38.8 - $55.46 $12.7 Million - $18.2 Million	-327,581 Reduced 47.63%	360,117 $18 Million
Q3 2022 Nov 14, 2022	BUY	$38.15 - $57.1 $16.9 Million - $25.4 Million	444,096 Added 182.3%	687,698 $28.1 Million
Q2 2022 Aug 15, 2022	SELL	$33.54 - $55.0 $10.8 Million - $17.7 Million	-322,322 Reduced 56.95%	243,602 $13.4 Million
Q1 2022 May 16, 2022	BUY	$31.02 - $48.18 $12.8 Million - $19.9 Million	413,890 Added 272.24%	565,924 $20.6 Million
Q4 2021 Feb 14, 2022	BUY	$41.14 - $56.98 $54,592 - $75,612	1,327 Added 0.88%	152,034 $7.09 Million
Q3 2021 Nov 15, 2021	BUY	$35.31 - $50.56 $3.28 Million - $4.7 Million	92,867 Added 160.56%	150,707 $7.62 Million
Q2 2021 Aug 16, 2021	BUY	$25.8 - $41.09 $1.05 Million - $1.67 Million	40,666 Added 236.79%	57,840 $2.37 Million
Q1 2021 May 17, 2021	BUY	$23.55 - $32.4 $404,447 - $556,437	17,174 New	17,174 $498,000
Q4 2020 Feb 16, 2021	SELL	$25.8 - $32.39 $3.37 Million - $4.24 Million	-130,802 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$27.5 - $39.61 $4.14 Million - $5.96 Million	-150,444 Reduced 53.49%	130,802 $4.04 Million
Q2 2020 Aug 14, 2020	BUY	$36.1 - $42.56 $10.2 Million - $12 Million	281,246 New	281,246 $12 Million

Others Institutions Holding LEGN

# of Institutions

237

Shares Held

60M

Call Options Held

591K

Put Options Held

381K

View Full List

About Legend Biotech Corp

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $6.19B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

More about LEGN

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account